Insulin neuritis and diabetic cachectic neuropathy: a review.
Knopp M, Srikantha M, Rajabally YA.
Curr Diabetes Rev. 2013 May;9(3):267-74. doi: 10.2174/1573399811309030007.
Murine model and mechanisms of treatment-induced painful diabetic neuropathy.
Nicodemus JM, Enriquez C, Marquez A, Anaya CJ, Jolivalt CG.
Neuroscience. 2017 Jun 23;354:136-145. doi: 10.1016/j.neuroscience.2017.04.036. Epub 2017 May 3.
Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication.
Rujescu D, Hartmann AM, Giegling I, Konte B, Herrling M, Himmelein S, Strupp M.
Front Neurol. 2018 Jul 20;9:591. doi: 10.3389/fneur.2018.00591. eCollection 2018.
Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.
Gibbons CH, Freeman R.
Ann Neurol. 2010 Apr;67(4):534-41. doi: 10.1002/ana.21952.
Acute diabetic neuropathy following improved glycaemic control: a case series and review.
Siddique N, Durcan R, Smyth S, Tun TK, Sreenan S, McDermott JH.
Endocrinol Diabetes Metab Case Rep. 2020 Feb 26;2020:19-0140. doi: 10.1530/EDM-19-0140. Online ahead of print.
C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Kamiya H, Zhang W, Ekberg K, Wahren J, Sima AA.
Diabetes. 2006 Dec;55(12):3581-7. doi: 10.2337/db06-0396.
Valproic Acid Suppresses Autoimmune Recurrence and Allograft Rejection in Islet Transplantation through Induction of the Differentiation of Regulatory T Cells and Can Be Used in Cell Therapy for Type 1 Diabetes.
Lin JR, Huang SH, Wu CH, Chen YW, Hong ZJ, Cheng CP, Sytwu HK, Lin GJ.
Pharmaceuticals (Basel). 2021 May 17;14(5):475. doi: 10.3390/ph14050475.
